Viewing Study NCT01521702


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-04-16 @ 5:37 PM
Study NCT ID: NCT01521702
Status: COMPLETED
Last Update Posted: 2015-03-20
First Post: 2011-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer
Sponsor: Institut Paoli-Calmettes
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module